期刊文献+

COX-2和Gal-3表达与甲状腺乳头状癌浸润转移的关系 被引量:6

Expressions of COX-2 and Gal-3 and Invasion and Metastasis in Papillary Thyroid Carcinoma
暂未订购
导出
摘要 目的探讨COX-2和Gal-3在甲状腺乳头状癌中的表达及其与癌组织浸润转移的关系。方法应用免疫组化染色EliVisionTMplus两步法检测164例甲状腺乳头状癌组织和30例癌旁甲状腺组织中COX-2和Gal-3的表达状况。结果癌组织COX-2和Gal-3总体阳性表达率分别为72.6%和92.1%,显著高于癌旁组织(P<0.05);有浸润和有淋巴结转移者COX-2和Gal-3阳性表达率均显著高于无浸润和无淋巴结转移者(P<0.05);癌组织COX-2与Gal-3表达呈正相关(r=0.38)。结论 COX-2和Gal-3在甲状腺乳头状癌组织中多数呈强阳性表达,两者与癌组织浸润转移密切相关。 Objective To investigate the expressions of COX-2 and Gal-3 in papillary thyroid carcinoma and their relationship with the invasion and metastasis. Methods The expressions of COX-2 and Gal-3 in 164 cases of papillary thyroid carcinoma and 30 cases of para-tumorous tissue were studied by EliVisionTM plus two-step immunohistochemical method. Results The positive rates of COX-2 and Gal-3 in papillary thyroid carcinoma were 72.6% and 92.1%, respectively, which were significantly higher than those in para-tumorous tissue (P〈0. 05). The positive rates of COX-2 and Gal-3 expression in the patients with tumor invasion and lymphatic metastasis were significantly higher than those without tumor invasion and lymphatic metastasis (P〈0.05). There was a positive correlation between COX-2 and Gal-3 expression (r=0.38). Conclusion High-level positive expressions of COX-2 and Gal-3 in papillary thyroid carcinoma were closely correlated with the invasion and metastasis.
出处 《河北北方学院学报(自然科学版)》 2016年第8期1-4,共4页 Journal of Hebei North University:Natural Science Edition
关键词 甲状腺肿瘤 COX-2 GAL-3 浸润 转移 thyroid carcinoma COX-2 Gal-3 tumor invasion metastasis
  • 相关文献

参考文献20

二级参考文献172

共引文献123

同被引文献101

  • 1谷化平,李德炳,张正猛,尚培中.P53和Sialyl Lewis-X表达与甲状腺乳头状癌侵袭转移的关系[J].西安交通大学学报(医学版),2005,26(1):71-73. 被引量:6
  • 2Ferenc T, Lewinski A, Lange D, et al. Analysis of nm23H1 protein immunoreactivity in follicular thyroid tumors[J]. Po[ J Pathol, 2004,55 (4) : 149-153.
  • 3Zafon C, Obiols G, Castellvi J, et al. Nm23H1 immu- noreactivity as a prognostic factor in differentiated thy- roid carcinoma[J]. J Clin Endocrinol Metab, 2001,86 (8) :3975-3980.
  • 4Shi Y, Zou M, Farid N R. The mystery of nm23H1 in thyroid cancer[J-~. J Endocrinol Invest, 2002, 25 (7) : 663-664.
  • 5Tabriz H M, Adahi K H, Lashkari A, et al. Immuno- histochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm [J]. PatholResPract, 2009,205(2)~83-87.
  • 6Shahebrahimi K, Madani S H, Fazaeli A R, et al. Di- agnostic value of CD56 and nm23 markers in papillary thyroid carcinoma[J]. Indian J Pathol Microbiol, 2013, 56(1) :2-5.
  • 7Tian X,Cong M, Zhou W, et al. Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer[J]. J Int Med Res,2008,36(4) : 699-703.
  • 8Wolinski K, Stangierski A, Szczepanek-Parulska E, et al. VEGF-C is a thyroid marker of malignancy superior to VEGF-A in the differential diagnosis of thyroid le- sion[J]. PLoS One,2016,11(2) :e150124.
  • 9Chang D F, Xu Z Q, Sun B. Relationship between VEGF protein expression and lymph node metastasisin papillary thyroid carcinoma among Asians: A meta- analysis[J]. Tumor Blot,2014, 35(6) :5511-5518.
  • 10Karaea Z, Tanriverdi F, Unluhizarci K, et al. VEGFR1 expression is related to lymph node metastasis and ser- um VEGF may be a marker of progression in the fol- low-up of patients with di{{erentiated thyroid carcino- ma[J]. Eur J Endocrinol,2011,164(2) :277-284.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部